Alejandra Victoria Capozzo 
ORCID 0000-0002-7117-9955

Alejandra Capozzo es directora de CAECIHS Buenos Aires e Investigadora Principal del CONICET en Tecnología y Veterinaria. Se graduó y doctoró en Ciencias Biológicas en la UBA, especializándose en vacunas contra la fiebre aftosa. Realizó estudios postdoctorales en la Universidad de Maryland y ha trabajado en empresas como Prionics AG (Suiza) y Biogénesis-Bagó.
Entre 2008 y 2011, dirigió el área de calidad del CEVAN, desarrollando nuevas técnicas serológicas y vacunas para fiebre aftosa y DVB. De 2011 a 2023, lideró el Laboratorio de Inmunología Veterinaria Aplicada en el Instituto de Virología (CONICET-INTA), con investigaciones en DVB y fiebre aftosa.
Ha publicado más de 50 trabajos científicos, escrito ocho libros y dirigido 12 tesis doctorales. Recibió varios premios INNOVAR, destacando su trabajo en un kit para detectar anticuerpos contra SARS-CoV-2 y el desarrollo de "Preven-Vir" para mejorar la producción bovina.

Publicaciones (2019-2024)

1. Chronic NOD2 stimulation by MDP confers protection against parthanatos through M2b macrophage polarization in RAW264.7 cells. Mansilla FC, Miraglia MC, Maidana SS, Cecilia R, Capozzo AV. Immunobiology. 2024 Jun 29;229(5):152833. doi: 10.1016/j.imbio.2024.152833.
2. An IgG1 single-dilution avidity ELISA predicts cross-protection against heterologous foot-and-mouth disease virus challenge after vaccination. Cardoso N, Eschbaumer M, Capozzo AV.V accine. 2024 Jun 13:S0264-410X(24)00707-2. doi: 10.1016/j.vaccine.2024.06.033.
3. Fasciola hepatica infection modifies IgG1 specific immune response to foot-and-mouth disease virus induced by vaccination. Costa M, Mansilla F, Manuel Sala J, Saravia A, Ubios D, Lores P, Capozzo AV, Freire T.Vaccine. 2024 Jan 25;42(3):541-547. doi: 10.1016/j.vaccine.2023.12.067.
4. Application of the Nagoya Protocol to veterinary pathogens: concerns for the control of foot-and-mouth disease. Horsington J, Abbeloos E, Kassimi LB, Boonsuya Seeyo K, Capozzo AV, Chepkwony E, Eblé P, Galdo-Novo S, Gizaw D, Gouverneur L, Grazioli S, Heath L, Hudelet P, Hyera JMK, Ilott M, King A, Lefebvre DJ, Mackay D, Metwally S, Mwiine FN, Nfon CK, Park MK, Pituco EM, Rosso F, Simon F, Ularamu HG, Vermeij P, Vosloo W, King DP.Front Vet Sci. 2023 Nov 22;10:1271434. doi: 10.3389/fvets.2023.1271434.
5. Kinetics of foot-and-mouth disease vaccine-induced antibody responses in buffaloes (Bubalus bubalis): avidity ELISA as an alternative to the virus neutralization test. Sala JM, Mansilla FC, Miraglia MC, Caspe SG, Perez-Filgueira DM, Capozzo AV.Front Vet Sci. 2023 Nov 7;10:1162477. doi: 10.3389/fvets.2023.1162477.
6. Enhanced infectivity of bovine viral diarrhoea virus (BVDV) in arginase-producing bovine monocyte-derived macrophages. Barone LJ, Cardoso NP, Mansilla FC, Castillo M, Capozzo AV.Virulence. 2023 Nov 15:2283899. doi: 10.1080/21505594.2023.2283899
7. Foot-and-mouth disease epidemiology, vaccines and vaccination: moving forward. Capozzo AV, Vosloo W, de Los Santos T, Pérez AM, Pérez-Filgueira M. Front Vet Sci. 2023 Jun 20;10:1231005. doi: 10.3389/fvets.2023.1231005
8. Women in veterinary epidemiology and economics. Capozzo AV, Vial F. Front Vet Sci. 2023 May 22;10:1212004. doi: 10.3389/fvets.2023.1212004
9. Assessment on Different Vaccine Formulation Parameters in the Protection against Heterologous Challenge with FMDV in Cattle. Di Giacomo S, Bucafusco D, Schammas JM, Pega J, Miraglia MC, Barrionuevo F, Capozzo AV, Perez-Filgueira DM.Viruses. 2022 Aug 15;14(8):1781. doi: 10.3390/v14081781.
10. FMD Research: Bridging the Gaps With Novel Tools. Capozzo AV, Pérez-Filgueira M, Vosloo W, Gay CG.Front Vet Sci. 2021 May 17;8:686141. doi: 10.3389/fvets.2021.686141.
11. Dying Alone Due to COVID-19: Do the Needs of the Many Outweigh the Rights of the Few-or the One? Capozzo AV. Frontiers in Public Health. 2020 Nov 30;8:593464. doi: 10.3389/fpubh.2020.593464.
12. Bovine Interferon Lambda Is a Potent Antiviral Against SARS-CoV-2 Infection in vitro. Cardoso NP, Mansilla FC, Benedetti E, Turco CS, Barone LJ, Iserte JA, Soria I, Baumeister E, Capozzo AV.Front Vet Sci. 2020 Nov 6;7:603622. doi: 10.3389/fvets.2020.603622
13. Interferon lambda protects cattle against bovine viral diarrhea virus infection. Quintana ME, Cardoso NP, Pereyra R, Barone LJ, Barrionuevo FM, Mansilla FC, Turco CS, Capozzo AV. Vet Immunol Immunopathol. 2020 Dec;2 30:110145. doi: 10.1016/j.vetimm.2020.
14. [Seroprevalence and risk factors associated with Neospora caninum in dairy farms from the Province of Salta, Argentina]. Pereyra WR, Suarez VH, Cardoso N, Gual I, Martínez GM, Capozzo AV, Mansilla FC.Rev Argent Microbiol. 2021 Apr-Jun;53(2):145-153. doi: 10.1016/j.ram.2020.06.011
15. The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine. Mansilla FC, Turco CS, Miraglia MC, Bessone FA, Franco R, Pérez-Filgueira M, Sala JM, Capozzo AV.PLoS One. 2020 May 5;15(5):e0232782. doi:10.1371/journal.pone.0232782.
16. In-vivo Activity of IFN-λ and IFN-α Against Bovine-Viral-Diarrhea Virus in a Mouse Model. Quintana ME, Barone LJ, Trotta MV, Turco C, Mansilla FC, Capozzo AV, Cardoso NP.Front Vet Sci. 2020 Feb 5;7:45. doi: 10.3389/fvets.2020.00045
17. Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory. Paton DJ, Reeve R, Capozzo AV, Ludi A.Vaccine. 2019 Sep 3;37(37):5515-5524. doi: 10.1016/j.vaccine.2019.07.102.
18. Immune cells transferred by colostrum do not influence the immune responses to foot-and-mouth disease primary vaccination. Bucafusco D, Pereyra R, Mansilla FC, Malacari DA, Juncos MS, Di Giacomo S, Ayude AF, Pérez-Filgueira M, Capozzo AV. J Dairy Sci. 2019 Sep;102(9):8376-8384. doi: 10.3168/jds.2018-15781.
19. Evidence of reduced vertical transmission of Neospora caninum associated with higher IgG1 than IgG2 serum levels and presence of IFN-γ in non-aborting chronically infected cattle under natural condition. Pereyra R, Mansilla FC, Petersen MI, Suarez V, Capozzo AV.Vet Immunol Immunopathol. 2019 Feb;208:53-57. doi: 10.1016/j.vetimm.2019.01.001.

Alicia Graciela Fuchs
ORCID 0000-0003-3621-6551

La Dra. Alicia G. Fuchs, médica desde 1981 y doctora en Patología Experimental en Oncología (1989), realizó varios postdoctorados en París, Madrid y Jerusalén, investigando sobre glicosilación de proteínas, canales de cloro y membranas de mielina. Trabajó en farmacología experimental y órganos bioartificiales en Israel. Desde 2006, fue directora del CAECIHS y, desde 2016, coordina el comité de ética del INP Fatala-Chaben. Actualmente es titular del CEI del ANLIS-Malbrán, investigando equinococosis quística. Ha dirigido varias tesis y colabora con CONICET en proyectos de investigación.

Publicaciones (2019-2024)

1. Characterization of the B-Cell Epitopes of Echinococcus granulosus Histones H4 and H2A Recognized by Sera From Patients With Liver Cysts. e-ISSN: 2235-2988 - Frontiers in Cellular and Infection Microbiology. (2022). Maglioco, Aguero, Valacco, Juarez Valdez, Paulino, Fuchs.  DOI: 10.3389/fcimb.2022.901994. eCollection 2022.
2. First report of cystic echinococcosis caused by Echinococcus granulosus sensu stricto/G1 in Felis catus from the Patagonian region of Argentina. ISSN: 0932-0113 - PARASITOLOGY RESEARCH (2021), Avila, Maglioco, Gertiser, Ferreyra, Ferrari, Klinger, Barbery Venturi, Aguero, Fuchs, Jensen DOIi: 10.1007/s00436-021-07048-4. 
3. Effect of Etidronate and Ibandronate on Cytosolic Ca2+ in HT29 and Parasite Cell Line from Echinococcus Granulosus sensu lato.ISSN: 1874-4214 - The Open Parasitology Journal (2019) Ferruli, Perz Rojo, Granada Herrera, Maglioco, Roldan, Fuchs.  DOI: 10.2174/1874421401907010019
4. Detection of Echinococcus granulosus sensu lato infection by using extracts derived from a protoscoleces G1 cell line. ISSN: 0141-9838 - PARASITE IMMUNOLOGY (2019) Maglioco, Gentile, barbery Venturi, Jensen, Hernandez, Gertiser, Poggio, Canziani, Fuchs. DOIi: 10.1111/pim.12674.

Publicaciones en libros sin DOI

1. Characterization of B-cell epitope of Echinococcus granulosus histons H4 and H2A recognized by sera from pstients with liver cyst.  Maglioco, Aguero, Valacco, Juarez Valdez, Paulino, Fuchs. (artículo de colección) Human in parasite and host ( 2021)ISBN 978-2-83252-079-6.
2. Articulo Destacado- Gatos domesticos con hidatidosis poliquistica abdominal en Patagonia Sur Argentina. Jensen, Gertiser, Correa, Delaplace, Díaz, Torresi, Maglioco, Fuchs, Avila. Anuario AAMeFe 2020. ISBN 978-987-47317-1-5.

Publicados en revista de UAI

1. Serological diagnosis in hydatidosis: Searching standardized antigenic support. Systematic review and meta-analysis. Retamozo, Aguero, Fuchs, Maglioco
   URLhttps://ijhsc.com/journal/article/view/41/10. (2021).
2. Trypanocidal effect of Diminazene aceturate by intranasal administration. Comparison among formulations. Fuchs, Santacruz, Fusco, Hoffer, Zhang, Esteva, Rial, Fichera, Cid, Gisone, De-Hua La, Bontempi. https://ijhsc.com/journal/article/view/33/11 (2021).

Andrea Maglioco
ORCID 0000-0002-7855-6071

Licenciada en Ciencias Biológicas por la Facultad de Ciencias Exactas y Naturales (FCEyN-UBA), obtuvo su Doctorado en Inmunología Tumoral en la Academia Nacional de Medicina. Actualmente es Investigadora Asistente de CONICET y realiza investigaciones sobre equinococosis quística en la Universidad Abierta Interamericana.

Publicaciones (2019-2024)

1. Maglioco A, Agüero FA, Valacco MP, Valdez AJ, Paulino M, Fuchs AG. Characterization of the B-Cell Epitopes of Echinococcus granulosus Histones H4 and H2A Recognized by Sera From Patients With Liver Cysts. Frontiers in cellular and infection microbiology 2022, vol. 12:901994. doi: 10.3389/fcimb.2022.901994
2. Retamozo A, Agüero FA, Fuchs A, Maglioco A. Serological diagnosis in hydatidosis: Searching standardized antigenic support. Systematic review and meta-analysis. Interamerican Journal of Health Sciences, 2021. https://doi.org/10.59471/ijhsc202141
3. Raffo D, Maglioco A, Fernandez Sasso D. A protocol for umbilical cord tissue cryopreservation as a source of mesenchymal stem cells. Mol Biol Rep. 2021, 48(2):1559-1565. doi: 10.1007/s11033-021-06206-2
4. Avila HG, Maglioco A, Gertiser ML, Ferreyra MP, Ferrari F, Klinger E, Barbery Venturi MS, Agüero FA, Fuchs AG, Jensen O. First report of cystic echinococcosis caused by Echinococcus granulosus sensu stricto/G1 in Felis catus from the Patagonian region of Argentina. Parasitol Res. 2021, 120(2):747-750. doi: 10.1007/s00436-021-07048-4.
5. Maglioco A, Gentile J, Barbery Venturi MS, Jensen O, Hernández C, Gertiser ML, Poggio V, Canziani G, Fuchs AG. Detection of Echinococcus granulosus sensu lato infection by using extracts derived from a protoscoleces G1 cell line. Parasite Immunol. 2019, 41(12):e12674. doi: 10.1111/pim.12674
6. Ferrulli M, Pérez Rojo FG, Granada Herrera LA, Maglioco A, Roldán EAJ, Fuchs AG. Effect of Etidronate and Ibandronate on Cytosolic Ca2+ in HT29 and Parasite Cell Line from Echinococcus granulosus sensu lato. The Open Parasitology Journal, 2019, 7: 19-25. doi: 10.2174/1874421401907010019

Capítulos de libros

1. Maglioco A, Agüero FA, Valacco MP, Valdez AJ, Paulino M, Fuchs AG. Characterization of the B-Cell Epitopes of Echinococcus granulosus Histones H4 and H2A Recognized by Sera From Patients With Liver Cysts, en De Koning-Ward., T. F., Touz, M. C., Singh, S., eds. (2023). Women in parasite and host 2021. Lausanne: Frontiers Media SA. doi: 10.3389/978-2-83252-079-6
2. Jensen O, Gertiser ML, Correa AI, Ferreyra MP, Devoto L, Delaplace M, Diaz Ghirardi, Torresi C, Maglioco AF, Fuchs AG, Ávila HG. Gatos domésticos con Hidatidosis Poliquística Abdominal en Patagonia Sur Argentina, artículo destacado en el Anuario 2020 / compilado por AAMeFe. - 1a ed. Ciudad Autónoma de Buenos Aires: Asociación Argentina de Medicina Felina, 2020. Libro digital, DOCX ISBN 978-987-47317-1-5.e

Jimena Paula Cabilla
ORCID 0000-0001-9625-6753

Jimena Paula Cabilla es Investigadora Adjunta del CONICET en oncología. Se graduó en Ciencias Biológicas con orientación en Biología Molecular y obtuvo su Doctorado en Ciencias Biológicas, especializándose en endocrinología, en la UBA. Realizó estudios doctorales y posdoctorales en Neuroendocrinología y Toxicología bajo la dirección de la Dra. Beatriz Duvilanski.
Ha sido docente en la FFyB-UBA y en la UAI. Ha publicado 22 artículos y más de 60 comunicaciones en congresos, y ha dirigido 4 tesis de licenciatura y una tesis doctoral en curso.

Publicaciones (2019-2024)

1. Challenging the norm: the unrecognized impact of soluble guanylyl cyclase subunits in cancer. Pino MT, Rocca MV, Acosta LH, Cabilla JP. International Journal of Molecular Sciences 2024 (en prensa). Guest author Special Edition cGMP: from bench to bedside.
2. Soluble guanylyl cyclase beta1 subunit targets epithelial-to-mesenchymal transition and downregulates Akt pathway in human endometrial and cervical cancer cells. Acosta LH, Pino MTL, Roccca MV, Cabilla JP. Heliyon 10(1):e23927. doi:10:1016/j.heliyon.2023.e23927.
3. Soluble guanylyl cyclase alpha1 subunit is a key mediator of proliferation, survival and migration in ECC-1 and HeLa cell lines. Ronchetti SA*, Pino MT*, Cordeiro G, Bollani SN, Ricci AG, Duvilanski BH, Cabilla JP. Scientific Reports 9(1):e14797-14808, 2019. doi:10.1038/s41598-019-51420-5. *equal contribution
4. Soluble guanylyl cyclase alpha1 subunit: a new marker for estrogenicity of endocrine disruptor compounds. Pino MT*, Ronchetti SA*, Cordeiro G, Bollani SN, Duvilanski BH, Cabilla JP. Environmental Toxicology and Chemistry 38(12):2719-2728, 2019. doi:10.1002/etc.4591. *equal contribution

Capítulos de libro

1. Soluble guanylyl cyclase alpha1 subunit as a biomarker of toxicity: applications to investigate endocrine-disrupting chemicals. Pino MTL, Cabilla JP. In Biomarkers in disease: methods, discoveries and applications. pp 1-21. Editorial Springer Nature, 2022. Https://link.springer.com/referencework/10.1007/978-3-030-87225-0#about.

María Teresa Pino
ORCID 0009-0009-2323-2721

María Teresa Pino es Investigadora Asistente del CONICET en toxicología. Se graduó en Biotecnología en la Universidad Nacional de Quilmes y obtuvo su Doctorado en Toxicología en la Facultad de Farmacia y Bioquímica de la UBA. Realizó estudios posdoctorales sobre disruptores endocrinos en el laboratorio de Neuroendocrinología y Toxicología bajo la dirección de la Dra. Beatriz Duvilanski.
Ha sido docente en la FFyB-UBA y en la Universidad Abierta Interamericana (UAI), en materias como Química Biológica Patológica, Genética Diagnóstica Forense y Escritura de Proyectos de Investigación. Ha publicado 6 artículos en revistas internacionales, capítulos de libro y 14 comunicaciones en congresos. Ha dirigido y codirigido 2 tesis de grado.

Publicaciones (2019-2024)

1. Challenging the norm: the unrecognized impact of soluble guanylyl cyclase subunits in cancer. Pino MT, Rocca MV, Acosta LH, Cabilla JP. International Journal of Molecular Sciences 2024 (en prensa). Guest author Special Edition cGMP: from bench to bedside.
2. Soluble guanylyl cyclase beta1 subunit targets epithelial-to-mesenchymal transition and downregulates Akt pathway in human endometrial and cervical cancer cells. Acosta LH, Pino MTL, Roccca MV, Cabilla JP. Heliyon 10(1):e23927. doi:10:1016/j.heliyon.2023.e23927.
3. Soluble guanylyl cyclase alpha1 subunit is a key mediator of proliferation, survival and migration in ECC-1 and HeLa cell lines. Ronchetti SA*, Pino MT*, Cordeiro G, Bollani SN, Ricci AG, Duvilanski BH, Cabilla JP. Scientific Reports 9(1):e14797-14808, 2019. doi:10.1038/s41598-019-51420-5. *equal contribution
4. Soluble guanylyl cyclase alpha1 subunit: a new marker for estrogenicity of endocrine disruptor compounds. Pino MT*, Ronchetti SA*, Cordeiro G, Bollani SN, Duvilanski BH, Cabilla JP. Environmental Toxicology and Chemistry 38(12):2719-2728, 2019. doi:10.1002/etc.4591. *equal contribution

Capítulos de libro

1. Soluble guanylyl cyclase alpha1 subunit as a biomarker of toxicity: applications to investigate endocrine-disrupting chemicals. Pino MTL, Cabilla JP. In Biomarkers in disease: methods, discoveries and applications. pp 1-21. Editorial Springer Nature, 2022. Https://link.springer.com/referencework/10.1007/978-3-030-87225-0#about

Francisco Capani
ORCID 0000-0003-0342-0628

El Dr. Capani es Docente Autorizado en Histología y Biología Celular en la Facultad de Medicina de la UBA y Profesor Titular en la UAJFK. Desde 2019, su grupo trabaja en el CAECHIS, donde está instalando un microscopio electrónico donado en 2014 por el KTH-Zurich.
Médico y Doctor en Medicina por la UBA, realizó su formación postdoctoral en el NCMIR (UCSD), Instituto Karolinska y Universidad de Marburg. Se ha especializado en neurociencias, particularmente en microscopía electrónica y tomografía 3D, y fundó el laboratorio de Citoarquitectura y Plasticidad Neuronal en 2006.
Ha trabajado en diversos centros internacionales y publicado más de 100 trabajos científicos. Ha dirigido 10 tesis doctorales, 2 de maestría, 15 tesinas de grado y 5 investigadores postdoctorales.

1. Otero-Losada M, Marseglia A, Blanco Calvo E, Capani F. (2023) Neurological comorbidity in metabolic syndrome. Front Neurosci. 15; 17:1263570. doi: 10.3389/fnins.2023.1263570. eCollection 2023. IF 5.2
2. Otero-Losada M, Gubellini P, Capani F, Perez-Lloret S. (2023) Neuroprotection and disease modification in Parkinson's disease: Volume II Front Pharmacol. 9;13:1121513. doi: 10.3389/fphar.2022.1121513.  I F 5.8
3. Nicolas Toro-Urrego, Tamara Kobiec, Sofia Bordet , Matilde Otero-Losada , Claudia Mardaraz , Camila Meloni, Carlos F Kusnier , Rodolfo Kolliker Frers , Juan Pablo Luaces , Francisco Capani  (2023) Neuroprotection during Hypoxia using Steroids Analogues. Microsc Microanal. 22;29 (29 Suppl 1):1141. doi: 10.1093/micmic/ozad067.583. IF 2.8
4. J P Luaces, N Toro-Urrego, M Otero-Losada, F Capani  (2023)  What do we know about blood-testis barrier? current understanding of its structure and physiology Front Cell Dev Biol. .; 11:1114769. doi: 10.3389/fcell.2023.1114769. IF 6
5. Tamara Kobiec , Claudia Mardaraz , Nicolás Toro-Urrego , Rodolfo Kölliker-Frers , Francisco Capani , Matilde Otero-Losada (2023) Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective. Front Neurosci. 10; 17:1214468. doi: 10.3389/fnins.2023.1214468. IF 5.2
6. Sofía Bordet, Juan Pablo Luaces, Maria Ines Herrera , Liliana Mirta Gonzalez , Tamara Kobiec , Santiago Perez-Lloret , Matilde Otero-Losada , Francisco Capani (2023) Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A traslacional perspective. Front Neurosci 15; 17:1215041. doi: 10.3389/fnins.2023.1215041. IF 5.2
7. Santiago Perez-Lloret, Guenson Chevalier, Sofia Bordet, Hanny Barbar, Francisco Capani, Lucas Udovin, Matilde Otero-Losada (2023) The Genetic Basis of Probable REM Sleep Behavior Disorder in Parkinson's Disease. Brain Sci. 30;13(8):1146. doi: 10.3390/brainsci13081146.
8. Guenson Chevalier, Lucas Udovin, Matilde Otero-Losada, Sofia Bordet, Francisco Capani, Sheng Luo, Christopher G Goetz, Santiago Perez-Lloret (2023) Genetics of Neurogenic Orthostatic Hypotension in Parkinson's Disease, Results from a Cross-Sectional In Silico Study. Brain Sci 17;13(3):506. doi: 10.3390/brainsci13030506.
9. Débora Loureiro, Rodrigo Bilbao, Sofía Bordet, Lina Grasso, Matilde Otero-Losada, Francisco Capani, Osvaldo J Ponzo, Santiago Perez-Lloret (2023) . A systematic review and meta-analysis on the association between orthostatic hypotension and mild cognitive impairment and dementia in Parkinson's disease. Neurol Sci.44(4):1211-1222. doi: 10.1007/s10072-022-06537-3.  IF 3.2
10. Otero-Losada M, Petrovsky N, Alami A, Crispo JA, Mattison D, Capani F, Goetz C, Krepski D, Perez-Lloret S. (2023) Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom. Expert Opin Drug Saf. 22(4):343-349. doi: 10.1080/14740338.2022.2120607.
11. Maria I. Herrera, Lucas D. Udovin, Tamara Kobiec, Nicolas Toro-Urrego, Carlos F. Kusnier\, Rodolfo Kölliker-Frers, Juan P. Luaces, Matilde Otero-Losada, Francisco Capani (2022) Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats. Front Behav Neurosci.  25; 16:953157. doi: 10.3389/fnbeh.2022.953157.  IF 3.2
12. Rodolfo Alberto Kölliker Frers, Matilde Otero-Losada, Tamara Kobiec, Lucas Daniel Udovin, Laura Aón, Maria Ines Herrera, Francisco Capani (2022) Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis” Front Immunol. 28; 13:912005. doi: 10.3389/fimmu.2022.912005. IF 8.2
13. Holubiec, Juan I. Romero, Claudia Urbainsky, Manuela Gellert, Pablo Galeano, Francisco Capani, Christopher Horst Lillig, Eva-Maria Hanschmann (2022) Nucleoredoxin Plays a Key Role in the Maintenance of Retinal Pigmented Epithelium Differentiation Mariana I. Antioxidants 11(6): 1106.  doi: 10.3390/antiox11061106. IF 7.6
14. Kölliker Frers R, Otero-Losada M, Kobiec T, Herrera MI, Udovin L, Kusnier CF, Capani (2022) F. Interleukin-1 Links Autoimmune and Autoinflammatory Pathophysiology in Mixed-Pattern Psoriasis. Mediators Inflamm.  16;2021:2503378. doi: 10.1155/2021/2503378.  IF 4.5
15. Otero-Losada M, Gubellini P, Capani F, Perez-Lloret S (2021). Neuroprotection and Disease Modification in Parkinson's Disease. Front Pharmacol.  8; 12:813471. doi: 10.3389/fphar.2021.813471.  IF 5.8
16. Kobiec T, Otero-Losada M, Chevalier G, Udovin L, Bordet S, Menéndez-Maissonave C, Capani F, Pérez-Lloret S (2021)  The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene.  Front Synaptic Neurosci.  22;13:638519. doi: 10.3389/fnsyn.2021.638519. IF. 4.24
17. Porta S, Otero Losada M,  Kolliker  RA, Cosentino V, Kerzberg E, Capani  F (2021)  Adipokines Cardiovascular Risk  and Therapeutic Management in Obesity and Psoriatic Arthritis Frontiers in Immunology 11DOI:10.3389/fimmu.2020.590749 . IF: 6.4.
18. Otero-Losada M, Wandosell FG, Capani F. (2021) Neuroprotection in Synaptic Signalling During Neurological Disorders.  Front Synaptic Neurosci. 13:746487. doi:  10.3389/fnsyn.2021.746487. 2021. IF;  3.25
19. Udovin L, Otero-Losada M, Bordet S, Chevalier G, Quarracino C, Capani F, Pérez-Lloret S. (2021) Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database. Parkinsonism Relat Disord. 27; 86:34-37. doi: 10.1016/j.parkreldis.2021.03.00. IF: 3.9.
20. Kölliker-Frers R, Udovin L, Otero-Losada M, Kobiec T, Herrera MI, Palacios J, Razzitte G, Capani F. (2021). Neuroinflammation: An Integrating Overview of Reactive-Neuroimmune Cell Interactions in Health and Disease. Mediators of Inflammation  https://doi.org/10.1155/2021/9999146. IF: 5.18
21. Otero-Losada M, Kobiec T, Udovin L, Chevalier G, Quarracino C, Menéndez Maissonave C, Bordet S, Capani F, Perez-Lloret S (2020). Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic. Front Neurol. 2020 Sep 11; 11:995. doi: 10.3389/fneur.2020.00995. IF 3.54
22. Herrera MI, Kobiec T, Kölliker-Frers R, Otero-Losada M, Capani F (2020). Synaptoprotection in Perinatal Asphyxia: An Experimental Approach. Front Synaptic Neurosci.  23; 12:35. doi: 10.3389/fnsyn.2020.00035. IF: 4.24
23. Udovin L, Quarracino C, Herrera MI, Capani F, Otero Losada M, Perez-Lloret S (2020) Role of Astrocytic dysfunction in the pathogenesis of Parkinson’s Disease animal models from a molecular signaling perspective Neural Plast. 7; 2020:1859431. doi: 10.1155/2020/1859431.  IF: 3.61.
24. Merlo S, Luaces JP, Spampinato SF, Toro-Urrego N, Caruso GI, D'Amico F, Capani F, Sortino (2020) MA. SIRT1 Mediates Melatonin's Effects on Microglial Activation in Hypoxia: In Vitro and In Vivo Evidence.  Biomolecules. 27;10(3). pii: E364. doi: 10.3390/biom10030364. IF 4.65.
25. Udovin LD, Kobiec T, Herrera MI, Toro-Urrego N, Kusnier CF, Kölliker-Frers RA, Ramos-Hryb AB, Luaces JP, Otero-Losada M, Capani F (2020).  Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia. Front Neurosci.13:1345. doi: 10.3389/fnins.2019.01345. IF: 3.57.
26. Otero-Losada M, Capani F. (2020) Oxidative Medicine in Brain Injury. Curr Pharm Des. 25(45):4735-4736. doi: 10.2174/138161282545200110113639. IF: 2.5.
27. Quarracino C, Otero-Losada M, Capani F, Pérez-Lloret S (2020). State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease. Expert Opin Pharmacol 20:1-13. doi: 10.1080/14656566.2020.1713097.  IF
28. Quarracino C, Otero-Losada M, Capani F, Pérez-Lloret S (2019). Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease. Clin Auton Res.  doi: 10.1007/s10286-019-00652-6.  IF 2.8.
29. Losada M, Canepa L, Udovin L, Kobiec T, Toro-Urrego N, Kölliker-Frers RA Capani F (2019). Long-Term Effects of Hypoxia-Reoxygenation On Thioredoxins In Rat Central Nervous System. Curr Pharm Des.  doi: 10.2174/1381612825666191211111926.  Indice de impacto: 2.5.
30. Holubiec MI1, Galeano P, Romero JI, Hanschmann EM, Lillig CH, Capani F (2019).   Thioredoxin 1 play a protective role in retinas exposed to perinatal hypoxia-ischemia.  Neuroscience pii: S0306-4522(19)30780-8. doi: 0.1016/j.neuroscience.2019.11.011. Indice de impacto: 3.25.
31. Herrera MI, Kölliker-Frers RA, Otero-Losada M, Perez Lloret S, Filippo M, Tau J, Capani F, Villa AM (2019) .A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis.Front Neurol. 2019 Oct 9;10:1046. doi: 10.3389/fneur.2019.01046. Indice de impact: 3.
32. Molina SJ, Buján GE, Rodriguez Gonzalez M, Capani F, Gómez-Casati ME, Guelman LR (2019) Exposure of Developing Male Rats to One or Multiple Noise Sessions and Different Housing Conditions: Hippocampal Thioredoxin Changes and Behavioral Alterations.  Front Behav Neurosci.  13; 13:182. doi: 10.3389/fnbeh. Indice de impacto:3.1.
33. Otero-Losada, Wandosell FG, Garcia-Segura LM, Capani F (2019) Neuroprotection in Brain Hypoxia. Front Neurosci.  22; 13:212. doi: 10.3389/fnins.2019.00212.Indice de impacto:3.7.

Capitulo de Libro

1. Neuroprotective Properties of Cannabinoids in Cellular and Animal Models: Hypotheses and Facts Lucas D. Udovin, Andrea Aguilar, Tamara Kobiec, María I. Herrera, Santiago Perez Lloret, Nicolás Toro Urrego and Rodolfo A. Kölliker Frers. and F Capani In  Neuroprotection New Approaches and Prospects, DOI: 10.5772/intechopen.92603
2. Neuroactive Steroids in Hypoxic–Ischemic Brain Injury: Overview and Future Directions By Nicolas Toro-Urrego, Marco Avila-Rodriguez, María Inés Herrera, Andrea Aguilar, Lucas Udovin Juan P. Luaces and F Capani  In  Neuroprotection New Approaches and Prospects, DOI: 10.5772/intechopen.92603
3. Inés Herrera, Tamara Kubiec, Matilde Otero-Losada, Francisco Capani (2020) In vivo protein Misfolding as a Novel Neuroprotective Target in Metabolic Syndrome’ Chronic Cerebral Hypoperfusion. In Neuroprotection New Approaches and Prospects, DOI: 10.5772/intechopen.92603
4. Gesivaldo Santos, Julita Maria Pereira Borges, Marcos Avila-Rodriguez, Érika Pereira Rubio, Cattiúscia Batista Bromochenkel, Djalma Menezes Oliveira, Jane Lima dos Santos, Rosane Moura Aguiar, Milena Mascarenhas Ferraz, Silvana Batista Gaino, Francisco Capani and George E. Barreto (2019) Mitochondrial KATP Channel and Dopaminergic Vulnerability Neurons in Parkinson’s Disease DOI: 10.5772/intechopen.81862 In Parkinson's Disease and Beyond - A Neurocognitive Approach.
5. Rodolfo Alberto Kölliker Frers, Matilde Otero-Losada, María Inés Herrera, Sabrina Porta, Vanesa Cosentino, Eduardo Kerzberg, Lucas Udovin and Francisco Capani (2019) Immune-mediated Inflammation: Human T CD4 helper lymphocyte diversity and plasticity in Health and Disease.  In Cells of the Immune Systems. Intechopen  DOI: 10.5772/intechopen.89230.